MYC and Miyoshi myopathy: Unlike other immunocompetent models of MM, such as the 5TGM1-KaLwRij model, the transplant Vk*MYC (Vk14551-GFP)/C57BL/6J MM model has the advantage of being relatively slow progressing with clinical features developing over ~ 9–12 weeks.